Tuberculosis is a global threat and a public health concern on a scale similar to COVID-19.
Academic rigour, journalistic flair
Articles on Tuberculosis (TB)
Displaying 61 - 80 of 179 articles
One of the main challenges remains that diagnostics and drugs for people suffering from advanced HIV aren’t readily available. This group of people is vulnerable to deadly opportunistic infections.
A COVID-19 vaccine isn’t the only tool for fighting this pandemic. An immunologist argues that safe pneumonia vaccines would reduce the severity of COVID-19, save lives and prevent the worst cases.
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
Our first exposure to a pathogen, either naturally or via vaccination, can affect how our immune system responds in the future to the same or similar pathogens.
Some insights into previous outbreaks of human coronaviruses may be useful in explaining the comparatively ‘low’ numbers of COVID-19 infections and mortality in people with HIV in South Africa.
Malaria, tuberculosis and HIV/AIDS are regarded as the ‘big three’ infectious diseases. This is where scientists are at in their efforts to find a vaccine for each one.
When Abbott Thayer’s wife succumbed to the disease, his life and art underwent a dramatic shift.
COVID-19 has stretched South Africa’s public health services to capacity. In response, the services have increased their capacity through innovation.
The redirection of resources to COVID-19 has enormous consequences for the provision of healthcare services for other diseases, in particular, HIV programmes.
The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they’re available to all.
A century ago, Australians were battling another pandemic, tuberculosis, with public health measures many will find familiar today.
The study of two hospitals was a first for researching the microbiology of the built environment in South Africa – a multi-disciplinary approach to understanding how to design healthier buildings.
A vaccine historically used to prevent tuberculosis is now among the contenders for a COVID-19 vaccine. So what is the BCG vaccine and why might it work against coronavirus?
Sunlight is not a cure for everything, and certainly not for COVID-19, but 100 years ago it was a popular treatment.
Australia has been tightening the border between PNG and the Torres Strait Islands in recent years, exacerbating poverty and the spread of tuberculosis in villages that depend on cross-border trade.
Blacks are dying at higher rates from COVID than whites, showing yet another example of gaps in outcomes between blacks and other groups. The cause is more sociological than biological.
Very little is known about the relationship between COVID-19 and HIV and TB. What is known is that people’s lungs are affected by all three.
Today is World TB Day. With attention turned toward coronavirus, it might seem too much to think about. But there’s a lot to consider about the role of young people in stopping both diseases.
Scientists need greater understanding of the bacterium’s basic biology, as well as more about how it is spread from one individual to the next.
Top contributors
-
Canada Research Chair of Epidemiology & Global Health, McGill University
-
Assistant Professor, Africa Health Research Institute (AHRI)
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Faculty Member, Africa Health Research Institute; Associate professor, UCL
-
Associate Professor, Melbourne Health
-
Honorary Research Associate, Centre for Infectious Disease Epidemiology and Research, University of Cape Town
-
Associate Professor in Paediatrics and Child Health, University of Sydney
-
Extraordinary Senior Lecture in the Department of Global Health, Stellenbosch University
-
Associate Professor of Biomedical Engineering, University of Michigan
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Infectious Diseases Physician and Senior Clinical Lecturer, Liverpool School of Tropical Medicine and Honorary Research Associate, University of Liverpool
-
Associate Professor, Pharmaceutical Sciences, University of the Western Cape
-
Faculty Member, Africa Health Research Institute; Wellcome Trust Senior Research Fellow, UCL
-
Associate Professor, SARChI Research Chair in Mycobactomics, Stellenbosch University
-
Head of the Division of Pulmonology, University of Cape Town
